Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
414.40    -2.40 (-0.58%)
Bid:
412.60
Ask:
413.40
Spread: 0.80 (0.194%)
Market Cap: £2.13b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Third Quarter Trading Update

13 Jan 2021 07:00

RNS Number : 4622L
QinetiQ Group plc
13 January 2021
 

News release

 

QinetiQ Group plc

Third Quarter Trading Update

13 January 2021 - QinetiQ Group plc ("QinetiQ" or "the Group") today issues a trading update covering its third quarter of trading.

Good momentum, maintaining expectations

Building on a strong first half to the financial year, the Group has continued to deliver well with continued strong performance through the third quarter. While we remain cautious and alert to the changing COVID-19 environment, we are on-track for our fifth consecutive year of organic growth and we continue to maintain our expectations for the full year, as outlined at our interim results in November 2020.

Our company has remained resilient and performance has continued to be strong, against the backdrop of the evolving COVID-19 pandemic. We adopted a three phase approach to working through the pandemic and our "renewal phase", the last of the three phases, is progressing well with a renewed ambition and evolved strategy to accelerate sustainable growth. We continue to adapt to our "new normal" ways of working with distributed teams delivering effectively and efficiently for our customers.

EMEA Services

EMEA Services has continued to have good momentum in the third quarter with very limited impact from COVID-19, as the division benefits from long-term contracts and delivers work that is critical to sovereign defence capabilities. We expect good organic revenue growth in EMEA Services for the year.

Global Products

Global Products has continued to show top line growth in the third quarter, driven by the contribution of our advanced sensing solutions business (formerly known as MTEQ), following disruption due to COVID-19 in the first half. Our Targets business is showing positive signs of recovery in the second half with some key orders being won.

Strategy Update

At our interim results in November 2020 we set out a renewed ambition and evolved strategy to accelerate sustainable growth of the company by delivering mission-led innovation for our customers' advantage. This renewed strategy is already yielding significant benefits:

-

Delivering on the LTPA: We are continuing to execute the modernisation programme, delivering successfully against all contractual KPIs and exceeding customer expectations; we remain on-track to deliver the final transition milestone on or ahead of schedule. In the quarter we hosted the UK and US Navy at our Hebrides ranges and we also completed the first training activities with the US Air Forces in Europe (USAFE) following our recent five year $27m contract win.

 

-

Delivery of RCV-L prototypes: In partnership with Pratt Miller Defense, we delivered the four prototype vehicles required to the US DoD ahead of schedule, under the Robotic Combat Vehicle Light programme, in advance of testing and experimentation in 2021.

 

-

£127m Typhoon EDP contract: We have won a five year contract through the Engineering Delivery Partner (EDP) framework providing a range of engineering services for Typhoon, from planning and acceptance through to regulatory assurance, trials support and optimisation of in-service capability. The contract is a significant milestone bringing total orders through EDP since its inception to in excess of £500m, as reported at our interim results.

 

-

Disposal of OptaSense: In the third quarter we announced completion of the disposal of OptaSense to Luna Innovations Inc for £29m. This was the third disposal completed this financial year for a combined enterprise value of £69m. These disposals were strategy-led decisions to optimise our portfolio bringing greater focus on our core strategy to build an integrated global defence and security company.

 

-

Acquisition of remaining Inzpire shareholding: In December 2020 we acquired the final 15% share capital of Inzpire Group Limited, two years after our initial strategic investment. Inzpire is a leading provider of operational training and mission systems for military customers in the UK and internationally. The business has performed well in the last two years, and remains important to our growing training and mission rehearsal campaign.

 

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

We will be running a virtual investor seminar on 4 March 2021 at 2pm GMT. Registration will be available on our website shortly.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Chris Barrie, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7968 727289

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDLLFFFFLEBBE
Date   Source Headline
26th Aug 202212:53 pmRNSDirector/PDMR Shareholding
10th Aug 20223:36 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSDelivering growth in the US with $45m contract win
5th Aug 20226:22 pmRNSProposed Acquisition of Avantus Federal LLC
1st Aug 20223:19 pmRNSHolding(s) in Company
21st Jul 20223:18 pmRNSResult of AGM
21st Jul 20227:00 amRNSFirst Quarter Trading Update
19th Jul 20225:24 pmRNSHolding(s) in Company
12th Jul 20222:09 pmRNSHolding(s) in Company
12th Jul 20221:47 pmRNSDirector/PDMR Shareholding
29th Jun 20225:09 pmRNSDirector/PDMR Shareholding
27th Jun 202212:35 pmRNSHolding(s) in Company
15th Jun 20229:53 amRNSHolding(s) in Company
13th Jun 202212:59 pmRNSDirector/PDMR Shareholding
13th Jun 202212:28 pmRNSAnnual Financial Report
6th Jun 202210:52 amRNSHolding(s) in Company
30th May 202212:03 pmRNSNotification of Major Shareholding
23rd May 20227:00 amRNSConfirmation of Full Year Results
19th May 20227:00 amRNSPreliminary Results
18th May 20227:00 amRNSDirectorate Change
17th May 202211:24 amRNSHolding(s) in Company
16th May 20221:45 pmRNSHolding(s) in Company
10th May 202211:49 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSInvestor Seminar: Delivering our global ambition
26th Apr 20221:37 pmRNSHolding(s) in Company
21st Apr 20229:15 amRNSHolding(s) in Company
20th Apr 20227:00 amRNSFourth Quarter Trading Update
12th Apr 202212:45 pmRNSDirector/PDMR Shareholding
10th Mar 202211:27 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
2nd Feb 20228:42 amRNSHolding(s) in Company
24th Jan 202211:12 amRNSDirector/PDMR Shareholding
19th Jan 20221:43 pmRNSHolding(s) in Company
18th Jan 20227:00 amRNSThird Quarter Trading Update
17th Jan 20227:00 amRNSAppointment of President and CEO of QinetiQ US
11th Jan 202211:43 amRNSDirector/PDMR Shareholding
5th Jan 20225:05 pmRNSDirector/PDMR Shareholding
20th Dec 20219:21 amRNSDirector Declaration
10th Dec 202112:42 pmRNSDirector/PDMR Shareholding
6th Dec 202112:16 pmRNSHolding(s) in Company
18th Nov 202111:04 amRNSDirector/PDMR Shareholding
17th Nov 202110:54 amRNSDirector/PDMR Shareholding
16th Nov 202111:24 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSInterim Results
10th Nov 202112:12 pmRNSDirector/PDMR Shareholding
1st Nov 202111:43 amRNSBlock listing Interim Review
19th Oct 20219:16 amRNSHolding(s) in Company
14th Oct 20217:00 amRNSTrading Update
12th Oct 202110:43 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.